Menu

Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience

By Correale Pierpaolo,Cusi Maria,Micheli Lucia,Nencini Cristina,Vecchio Maria,Torino Francesco,Aquino Angelo,Bonmassar Enzo,Francini Guido,Giorgi Giorgio in (2006)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Novel in vitro model barriers for evaluation of the permeability of antitumor compounds, thioxanthones

By Marasanapalle Venugopal,Li Xiaoling,Polin Lisa,Jasti Bhaskara in (2006)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Phase I study of gefitinib, oxaliplatin, 5-fluorouracil, and leucovorin (IFOX) in patients with advanced solid malignancies

By Cho Cheryl,Fisher George,Halsey Joanne,Sikic Branimir in (2006)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

A phase I safety and dose escalation trial of docetaxel combined with GEM®231, a second generation antisense oligonucleotide targeting protein kinase A R1α in patients with advanced solid cancers

By Goel Sanjay,Desai Kavita,Macapinlac Manuel,Wadler Scott,Goldberg Gary,Fields Abbie,Einstein Mark,Volterra Fabio,Wong Benny,Martin Russell,Mani Sridhar in (2006)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinoma

By Heath Elisabeth,Burtness Barbara,Kleinberg Lawrence,Salem Ronald,Yang Stephen,Heitmiller Richard,Canto Marcia,Knisely Jonathan,Topazian Mark,Montgomery Elizabeth,Tsottles Nancy,Pithavala Yazdi,Rohmiller Bridget,Collier Mary,Forastiere Arlene in (2006)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinoma

By Peterson Amy,Harlin Helena,Karrison Theodore,Vogelzang Nicholas,Knost James,Kugler John,Lester Eric,Vokes Everett,Gajewski Thomas,Stadler Walter in (2006)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Multicenter phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer (Study 1): West Japan Thoracic Oncology Group (WJTOG) trial

By Sawa Toshiyuki,Yana Takashi,Takada Minoru,Sugiura Takahiko,Kudoh Shinzoh,Kamei Tadashi,Isobe Takeshi,Yamamoto Hidehiko,Yokota Soichiro,Katakami Nobuyuki,Tohda Yuji,Kawakami Akira,Nakanishi Yoichi,Ariyoshi Yutaka in (2006)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Phase II trial of DNA methyltransferase 1 inhibition with the antisense oligonucleotide MG98 in patients with metastatic renal carcinoma: A National Cancer Institute of Canada Clinical Trials Group investigational new drug study

By Winquist Eric,Knox Jennifer,Ayoub Jean-Pierre,Wood Lori,Wainman Nancy,Reid Gregory,Pearce Laura,Shah Ajit,Eisenhauer Elizabeth in (2006)

Springer Publishing Company

Abstract Access to resources Recommend Favorite